Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

IMUX — IMMUNIC, INC. SEC Filings | FilingIndex

IMUXNasdaq

IMMUNIC, INC.

Pharmaceutical Preparations · DE · CIK 1280776

Immunic, Inc. develops novel oral therapies for neurologic and gastrointestinal diseases

red 8-K · 90d

+ Watch View on EDGAR ↗

$189M

Market cap

$15.41

Last close

+0.7%

1D

+4.5%

5D

358K

Volume

Price · last 39 sessions+45.1%

May 4L $10.62 · H $15.41Jun 29

317

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 172 10-Q · 37 424B5 · 21 SC 13G · 20 DEF 14A · 14 10-K · 12 DEFA14A · 9 S-1/A · 8

SC 13GIMMUNIC, INC.Nov 12, 2024 SC 13GSCHEDULE 13GJan 18, 2024 SC 13GSC 13GJan 16, 2024 SC 13GSCHEDULE 13GJan 10, 2024 SC 13GSC 13GNov 28, 2022 SC 13G

Similar companies

Comparable business profile · signals at a glance

ZBIOZenas BioPharma, Inc.$1.3B-1.2%CTNMContineum Therapeutics, Inc.$444.2M+5.7%NRIXNurix Therapeutics, Inc.🔥$1.8B+4.2%TGTXTG THERAPEUTICS, INC.$7.6B-0.2%IMVTImmunovant, Inc.

SC 13G

Nov 25, 2022

SC 13GSC 13GNov 25, 2022

SC 13GSCHEDULE 13GOct 24, 2022

SC 13GSC 13GOct 21, 2022

SC 13GSC 13GOct 20, 2022

SC 13GIMMUNIC, INC.Feb 14, 2022

SC 13GSC 13GFeb 19, 2021

SC 13GSC 13GFeb 8, 2021

SC 13GACQUISITION OF BENEFICIAL OWNERSHIPMay 4, 2020

SC 13GSC 13GDec 20, 2019

SC 13GVITAL THERAPIES INC 13G 073116Sep 23, 2016

SC 13GVITAL THERAPIES, INC.Feb 12, 2016

SC 13GSCHEDULE 13GNov 5, 2015

SC 13GSC 13GFeb 13, 2015

SC 13GSC 13GFeb 12, 2015

$6.9B

-0.9%

PALIPALISADE BIO, INC.$297.2M+18.0%